Collagenous Colitis Clinical Trial
Official title:
Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Budesonide Capsules vs. Mesalazine Granules vs. Placebo for Patients With Collagenous Colitis.
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.
This study will check the reproducibility of the results reported in trials with budesonide in patients with collagenous colitis. Efficacy of mesalazine was never tested in collagenous colitis by placebo-controlled trials. This trial will check the superiority of mesalazine over placebo using the common clinical symptom of collagenous colitis, which is chronic or recurrent non-bloody, watery diarrhea. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00139165 -
Long-Term Treatment of Collagenous Colitis With Budesonide
|
Phase 3 | |
| Not yet recruiting |
NCT03658993 -
Rifaximin-treatment of Collagenous Colitis
|
Phase 3 | |
| Recruiting |
NCT01504048 -
Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
|
N/A | |
| Completed |
NCT01928667 -
Case-Control Study to Identify Risk Factors for Microscopic Colitis
|
N/A | |
| Completed |
NCT00180076 -
Budesonide for Maintenance Treatment of Collagenous Colitis
|
Phase 3 |